Short-term magnesium deficiency results in decreased levels of serum sphingomyelin, lipid peroxidation, and apoptosis in cardiovascular tissues

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 1, 2009, Pages

  Altura, Burton M ^a,c   Shah, Nilank C ^a   Jiang, Xian Cheng ^b   Li, Zhiqiang ^b   Perez Albela, José Luis ^d   Sica, Anthony C ^a   Altura, Bella T ^a,c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c SUNY Downstate Medical Center   (United States)

^d Instituto Bien de Salud   (Peru)

Author keywords

Calcium; Caspase 3; Deoxyribonucleic acid fragmentation; Phosphatidylcholine

Indexed keywords

CASPASE 3; MAGNESIUM; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIETARY INTAKE; DNA FRAGMENTATION; ENZYME ACTIVATION; FEMALE; FLUID INTAKE; HEART ATRIUM; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HEART VENTRICLE; LIPID PEROXIDATION; MAGNESIUM DEFICIENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; BLOOD VESSELS; CALCIUM; CASPASE 3; DIET; DNA FRAGMENTATION; DRINKING; EATING; FEMALE; LIPID PEROXIDATION; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MALONDIALDEHYDE; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; PHOSPHATIDYLCHOLINES; RATS; RATS, WISTAR; SPHINGOMYELINS;

EID: 67650085248     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01154.2008     Document Type: Article

References (55)

1. Altura BM, Altura BT. Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res 41: 347-359, 1995.
2. Altura BM, Altura BT. Magnesium: forgotten mineral in cardiovascular biology and atherogenesis. In: New Perspectives in Magnesium Research, edited by Nishizawa N, Morii H, and Durlach J. New York: Springer, 2007, p. 239-260.
3. Altura BM, Altura BT, Gebrewold A, Ising H, Gunther T. Magnesium deficiency and hypertension: correlation between magnesium deficient diets and microcirculatory changes in situ. Science 223: 1315-1317, 1984.
4. Altura BM, Gebrewold A, Zheng T, Altura BT. Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: insight into mechanisms and possible relation to brain injury and stroke. Brain Res Bull 58: 271-278, 2002.
5. 2+ in aortic and cerebral vascular smooth muscle cells: possible links to hypertension, atherogenesis and stroke. Am J Hypertens 16: 701-707, 2003.
6. 31P-NMR study. Biochim Biophys Acta 1182: 329-332, 1993.
7. Altura BT, Altura BM. Measurement of ionized magnesium in whole blood, plasma and serum with a new ion-selective electrode in healthy and diseased human subjects. Magnes Trace Elem 10: 90-98, 1991.
8. Altura BT, Brust M, Barbour RL, Stempak J, Altura BM. Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci USA 87: 1840-1844, 1990.
9. Altura BT, Memon ZI, Zhang A, Cracco RQ, Altura BM. Low levels of serum ionized magnesium are found in patients early after stroke which result in rapid elevation in cytosolic free calcium and spasm in cerebral vascular smooth muscle cells. Neurosci Lett 230: 37-40, 1997.
10. Bischoff A, Czyborra P, Fetscher C, Meyer Zu Heringdorf D, Jakobs KH, Michel MC. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. Br J Pharmacol 130: 1871-1877, 2000.
11. Burton K. A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62: 315-323, 1956.
12. Chipperfield B, Chipperfield JR. Relation of myocardial metal concentrations to water hardness and death from ischemic heart disease. Lancet 2: 709-712, 1979.
13. Durlach J, Bara M, Guiet-Bara A. Magnesium level in drinking water and cardiovascular risk factor: a hypothesis. Magnesium 4: 5-15, 1985.
14. Eisenberg MJ. Magnesium deficiency and sudden death. Am Heart J 124: 544-549, 1992.
15. Ford ES, Mokdad AH. Dietary magnesium intake in a national sample of US adults. J Nutr 133: 2879-2882, 2003.
16. Gueux E, Mazor A, Cardot P, Rayssiguier Y. Magnesium deficiency affects plasma lipoprotein composition in rats. J Nutr 121: 1222-1227, 1991.
17. Hannun YA. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269: 3125-3128, 1994.
18. Hannun YA. Functions of ceramide in coordinating response to stress. Science 274: 1855-1859, 1996.
19. Jaffrezou JP, Maestre N, de Mas-Mansat V, Bezombes C, Levade T, Laurent G. Positive feedback control of sphingomyelinase activity by ceramide. FASEB J 12: 999-1006, 1998.
20. Jiang XC, Paultre F, Pearson TA, Reed RG, Francis CK, Lin Berglund L, Tall AR. Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol 20: 2614-2618, 2000.
21. Kaplan LA, Pesce AJ, Kazmierczak SC. Clinical Chemistry. Theory, Analysis, Correlation (4th ed.). St. Louis: Mosby, 2003.
22. Kobayashi J. On geographical relationship between the chemical nature of river water and death from apoplexy. Berichte des Ohara Inst fur Landwirtsch Biol 11: 12-21, 1957.
23. Kolesnick R. Signal transduction through the sphingomyelin pathway. Mol Chem Neuropathol 21: 287-297, 1994.
24. Kramer JH, Misík V, Weglicki WB. Magnesium-deficiency potentiates free radical production associated with postischemic injury in rat hearts: vitamin E affords protection. Free Radic Biol Med 16: 713-723, 1994.
25. Kuksis A, Roberts A, Thompson JS, Myher JJ, Geher K. Plasma phosphatidylcholine/free cholesterol ratio as an indicator for atherosclerosis. Arteriosclerosis 3: 389-397, 1983.
26. Leary WP. Content of magnesium in drinking water and deaths from ischemic heart disease in white South Africans. Magnesium 5: 150-153, 1986.
27. 2+]i in rat aortic smooth muscle cells: possible roles of extracellular and intracellular magnesium ions in peroxynitrite-induced cell death. Drug Metab Lett 1: 85-89, 2007.
28. Mahfouz MM, Zhou Q, Kummerow FA. Cholesterol oxides in plasma and lipoproteins of magnesium-deficient rabbits and effects of their lipoproteins on endothelial barrier function. Magnes Res 7: 207-222, 1994.
29. Marier JR, Neri LC. Quantifying the role of magnesium in the interrelationship between human mortality/morbidity and water hardness. Magnesium 4: 53-59, 1985.
30. Marx A, Neutra RR. Magnesium in drinking water and deaths from ischemic heart disease. Epidemiol Rev 19: 258-272, 1997.
31. Matassov D, Kagan T, Leblanc J, Sihorska M, Zakari Z. Measurement of apoptosis by DNA fragmentation. In: Apoptosis Methods and Protocols, edited by Brady HJ. Totowa: Humana, 2004, p. 1-17.
32. 2+ modulates membrane lipids in vascular smooth muscle: a link to atherogenesis. FEBS Lett 408: 191-194, 1997.
33. 2+ modulates membrane sphingolipids and lipid second messengers levels in vascular smooth muscle cells. FEBS Lett 440: 167-171, 1998.
34. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science 259: 1769-1771, 1993.
35. Quillet J, Kilkus J, McShan CL, Gottschalk AR, Dawson G. Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and irradiation. Biochem Biophys Res Commun 202: 710-714, 1994.
36. Ramos B, Salido GM, Campo ML, Claro E. Inhibition of phosphatidylcholine synthesis preceding apoptosis induced by C2-ceramide: protection by exogenous phosphatidylcholine. Neuroreport 11: 3103-3108, 2000.
37. Ravid T, Tsaba A, Gee P, Rasooly R, Medina EA, Goldkorn T. Ceramide accumulation precedes caspase-3 activation during apoptosis of A549 human lung adenocarcinoma cells. Am J Physiol Lung Cell Mol Physiol 284: L1082-L1092, 2003.
38. 2+ calmodulin antagonist chlorpromazine and poly(ADP-ribose) polymerase modulators 4-aminobenzamide and nicotinamide influence hepatic expression of BCL-XL and P53 and protect against acetaminophen-induced programmed and unprogrammed cell death in mice. Free Radic Biol Med 31: 277-291, 2001.
39. Rayssiguier Y, Gueux E. Magnesium and lipids in cardiovascular disease. J Am Coll Nutr 5: 507-519, 1986.
40. Rayssiguier Y, Gueux E, Bussiere L, Durlach J, Mazur A. Dietary magnesium affects susceptibility of lipoproteins and tissues to peroxidation in rats. J Am Coll Nutr 12: 133-137, 1993.
41. Rock E, Astier C, Lab C, Vignon X, Gueux E, Motta C, Rayssiguier Y. Dietary magnesium deficiency in rats enhances free radical production in skeletal muscle. J Nutr 125 1205-1210, 1995.
42. Rubenowitz E, Molin I, Axelsson G, Rylander R. Magnesium in drinking water in relation to morbidity and mortality from acute myocardial infarction. Epidemiology 11: 416-421, 2003.
43. Schroeder HA. Relations between hardness of drinking water and deaths from certain chronic and degenerative diseases in the United States. J Chronic Dis 12: 586-591, 1960.
44. Singh RB. Magnesium status and risk of coronary artery disease in rural and urban populations with variable magnesium consumption. Magnes Res 1: 205-213, 1997.
45. Smyth MJ, Perry DK, Zhang J, Poirier GG, Hannun YA, Obeid LM. prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. Biochem J 316: 25-28, 1996.
46. Starcevic SL, Elferink C, Novak RF. Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease. J Natl Cancer Inst 93: 776-782, 2001.
47. 2+ deficiency induces cardiac apoptosis in the rat heart. Magnes Res 20: 208-212, 2007.
48. Tongyai S, Rayssiguier Y, Motta C, Gueux E, Maurois P, Heaton FW. Mechanism of increased erythrocyte membrane fluidity during magnesium deficiency in weanling rats. Am J Physiol Cell Physiol 257: C270-C276, 1989.
49. Vaandrager AB, Houweling M. Effect of ceramides on phospholipid biosynthesis and its implications for apoptosis. In: Phospholipid Metabolism in Apoptosis, edited by Quinn PJ and Kagan VE. New York: Kluwer Academic, 2002, p. 207-227.
50. Weglicki WB, Mak IT, Dickens BF, Stafford RE, Komarov AM, Gibson B, Cassidy MM, Phillips TM, Kramer JH. Neuropeptides, free radical stress and antioxidants in models of Mg-deficient cardiomyopathy. In: Magnesium: Current Status and New Developments, edited by Theophanides Y and Anastassopolou J. London: Kluwer Academic, 1997, p. 169-178.
51. Weglicki WB, Phillips TM, Freedman AM, Cassidy MM, Dickens BF. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 118: 105-111, 1992.
52. Wu F, Altura BT, Gao J, Barbour RL, Altura BM. Ferrylmyoglobin formation induced by acute magnesium deficiency in perfused rat heart causes cardiac failure. Biochim Biophys Acta 1225: 158-164, 1994.
53. Wymann MP, Schneiter R. Lipid signaling in disease. Nat Rev Mol Cell Biol 9: 162-176, 2008.
54. Yen CL, Mar MH, Ziesel SH. Choline-deficiency-induced apoptosis in PC12 cells is associated with diminished phosphatidylcholine and sphingomyelin, accumulation of ceramide and diacylglycerol, and activation of a caspase. FASEB J 13: 135-142, 1999.
55. i in canine cerebral vascular muscle. Am J Physiol Heart Circ Physiol 278: H1421-H1428, 2000.